On January 11, 2021 Herantis Pharma Plc ("Herantis"), an innovative drug development company pioneering new disease modifying and regenerative biologic and gene therapies, reported that Craig Cook, Chief Executive Officer of Herantis, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference taking place January 11-14, 2021 (Press release, Herantis Pharma, JAN 11, 2021, View Source;wainwright-bioconnect-2021-virtual-conference,c3265921 [SID1234577473]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The video webcast presentation will be available for viewing on-demand beginning Monday, January 11, 2021, at 6:00 ET / 13:00 EET / 12:00 CET. To access the live webcast of Herantis’ live presentation, please visit: View Source

A replay of the webcast can be accessed for up to 90 days following the live presentation.